Navigating New Jersey  Medical Cannabis Laws

 

In 2010, New Jersey enacted the Compassionate Use Medical Marijuana Act, creating a medical cannabis program for patients with qualifying medical conditions. The state later expanded the program through the Jake Honig Compassionate Use Medical Cannabis Act, including broader qualifying conditions, additional patient protections, and expanded access through licensed Alternative Treatment Centers and other cannabis businesses.

Registered patients may purchase medical cannabis from licensed dispensaries with authorization from participating healthcare practitioners. State rules govern patient registration, caregiver participation, product forms, testing, labeling, and where cannabis may be used. New Jersey legalized adult use in 2020.

68,077
Registered Patient Population		 0.73%
of Total Population Represented by Patients		 193
Total Medical Retail Locations Currently in Operation		 353 : 1
Patients : Retail

*UPDATE: AG ORDER NO. 6754-2026 CHANGED FEDERAL CANNABIS LAWS ON APRIL 28, 2026. Learn more here. It is important to stay active, engaged, and informed. Sign up to get ASA updates.

Patients and their caregivers should be aware that their rights and legal protections* vary by state, age, and even the chemical composition of a product. Medical professionals have federal protections to discuss cannabis medicines with their patients, but incorporating them into their patients' treatment regimen is a very different process than writing a prescription. Laws and regulations are constantly evolving and require consistent advocacy to ensure better patient outcomes.

Americans for Safe Access has taken the guesswork out of navigating applicable laws, regulations, and available resources with these stakeholder resources.  

 

 

*UPDATE: AG ORDER NO. 6754-2026 CHANGED FEDERAL CANNABIS LAWS  ON APRIL 28, 2026: Learn more here.

Federal cannabis laws affect far more than whether a patient can access medical cannabis. For decades, federal prohibition has limited protections for medical cannabis patients under laws such as the Americans with Disabilities Act (ADA) and the Fair Housing Act (FHA). As a result, patients have often been denied the basic protections that people with other serious health conditions expect in employment, housing, healthcare, and access to federal programs.

Federal prohibition has also affected patients’ access to essential healthcare, housing, and financial support programs, sometimes forcing patients to choose between the medicine they need and the benefits they depend on. It has also created barriers to federal employment, healthcare autonomy, firearm ownership, and other aspects of daily life.

As federal and state cannabis laws change, implementation matters. Advocates must stay vigilant to ensure public agencies, private institutions, employers, housing providers, and healthcare systems update their policies in ways that respect patient rights and protect safe, legal access to medical cannabis.

It is important to stay active, engaged, and informed. Sign up to get ASA updates and learn more about ending patient discrimination. 

Cannabis, in its natural form, is inherently safe for most patients, but it is especially susceptible to contaminants during cultivation, manufacturing, handling & even storing. Whether you are purchasing cannabis from regulated, grey, or illicit markets or cultivating your own cannabis, you should be aware of the contaminants commonly found in cannabis and the symptoms that accompany their presence.

Products sold in New Jersey medical dispensaries and adult-use retail locations must be tested for contaminants, pesticides, and adulterants in accordance with thresholds set by state regulators. Click here to see specific requirements for New Jersey products.

For more information about cannabis safety, download ASA's "What’s in Your Cannabis? A Patient & Consumer Guide to Navigating Cannabis Safety."

NOTICE: It can be challenging for patients to determine which businesses offering cannabis products are licensed and approved by the state. Use this resource to find state-licensed medical cannabis retailers.

Stigma and discrimination also make patients targets for law enforcement encounters. Keep in mind that the best law enforcement encounter is the one that never occurs! It's crucial for individuals involved in medical cannabis to understand not only medical cannabis laws and regulations but also their rights. Be Prepared. Learn about Your Rights! 

Check out ASA's travel guide for patients and caregivers for tips on what to know before you go!

Get Involved! Learn more about ASA Campaigns and Take Action to improve the lives of medical cannabis patients today! 

If you appreciate ASA's work, join now to become a part of the movement & sign up to get ASA updates

Patient Rights and Civil Protections 70/100   
Arrest Protection 25/25
Affirmative Defense 20/20
Parental Rights Protections 0/20
DUI Protections 0/10
Employment Protections 20/20
Explicit Privacy Standards 5/5
Access to Medicine 55/100   
Authorizes Retail Access 10/10
Alternative Accessibility Methods 20/20
- Authorizes Delivery 10/10
- Authorizes Curbside Pickup 10/10
Personal Cultivation 0/15
Collective Gardening 0/5
Sufficient Number of Licensed Retailers 5/30
Reciprocity 20/20
Program Functionality 76/100   
Legal Protections Within Reasonable Time Frame 16/20
Reasonable Possession Limits 10/10
Reasonable Purchase Limits 5/10
Telemedicine for Physician Certifications 8/15
Patient and Physician Representation in Program Decision Making 15/20
Reasonable Caregiver Standards 2/5
- Background Checks 0/2
- Number of Caregivers 2/3
Reasonable Physician Standards 5/5
Access to Administration Methods 10/10
- Allows Dried Flower 5/5
- Allows Edibles, Concentrates, and Other Forms 5/5
Provides Access to Minors on School Grounds 5/5
Affordability 63/100   
Sales Tax Break for Patients and Caregivers 16/20
Covered by State Insurance or Health Aid 7/20
Reasonable Registration Fees 20/20
Financial Hardship Waivers or Discounts 10/20
Donation Program 0/10
Allows Multi-Year Registrations 10/10
Health and Social Equity 58/100   
State Program Protections 25/25
Housing Protections 0/25
Access for Minors 8/10
Access in Underserved Areas 2/10
List of Qualifying Conditions is Exhaustive or All Inclusive 9/10
Allows Patients to Medicate Where they Choose 4/10
Organ Transplants 5/5
Ownership or Employment Restrictions 5/5
Consumer Protection and Product Safety 151/200   
Cultivation Operations 41/50
Quality Management Systems 10/10
Staff Training 10/10
Standard Operating Procedures 8/8
- Facility and Equipment Sanitation 1/1
- Workplace Safety 1/1
- Storage 1/1
- Batch and Lot Tracking 1/1
- Security 1/1
- Waste Disposal 1/1
- Water Management 1/1
- Records Management 1/1
Pesticide Usage Limitations 2/2
Environmental Impact Regulations 2/2
Required Testing 5/8
- Cannabinoids 1/1
- Terpenes 0/1
- Microbials 1/1
- Aflatoxins 0/1
- Pesticides 1/1
- Heavy Metals 1/1
- Foreign Matter 1/1
- Moisture Content/ Water Activity 0/1
Packaging and Labeling 1/3
- Cannabinoids 1/1
- Terpenes 0/1
- Pesticides 0/1
Complaints, Adverse Event Reporting, and Recall Protocol 3/7
Manufacturing Operations 41/50
Quality Management Systems 10/10
Staff Training 10/10
Standard Operating Procedures 7/7
- Facility and Equipment Sanitation 1/1
- Workplace Safety 1/1
- Storage 1/1
- Batch and Lot Tracking 1/1
- Security 1/1
- Waste Disposal 1/1
- Records Management 1/1
Environmental Impact Regulations 3/3
Required Testing 6/10
- Cannabinoids 1/1
- Terpenes 0/1
- Microbials 1/1
- Aflatoxins 0/1
- Pesticides 1/1
- Heavy Metals 1/1
- Residual Solvents 1/1
- Homogeneity 0/1
- Foreign Matter 1/1
- Water Activity 0/1
Packaging and Labeling 2/5
- Cannabinoids 1/1
- Terpenes 0/1
- Ingredients 1/1
- Allergens 0/1
- Nutritional Content 0/1
Complaints, Adverse Event Reporting and Recall Protocol 3/5
Dispensary Operations 34/50
Staff Training 20/20
Standard Operating Procedures 7/7
- Facility Sanitation 1/1
- Workplace Safety 1/1
- Storage 1/1
- Batch and Lot Tracking 1/1
- Security 1/1
- Waste Disposal 1/1
- Records Management 1/1
Product Testing 0/10
- Product Meets Requirements Before Sale 0/5
- COA Disclosure 0/5
Complaints, Adverse Event Reporting and Recall Protocol 7/13
Laboratory Operations 35/50
Independent or Third-Party 5/5
Laboratory Sampling 0/5
Method Validation 4/4
Quality Management Systems 5/5
Staff Training 10/20
Standard Operating Procedures 7/7
- Facility and Equipment Sanitation 1/1
- Equipment and Instrument Calibration 1/1
- Workplace Safety 1/1
- Sample Tracking 1/1
- Security 1/1
- Waste Disposal 1/1
- Records Management 1/1
Result Reporting 4/4
Score Penalties 20/100   
Gives Regulatory Preference to Adult Use 20/20
Classifies Cannabis as a Medicine of Last Resort 0/15
Administrative or Supply Problems 0/15
Requires Vertical Integration 0/10
Creates New Criminal Penalties for Patients 0/10
Limits Patients to a Single Retailer 0/10
No System for Adding Qualifying Conditions 0/10
Imposes Bans or Limits on THC 0/5
Imposes Bans or Limits on CBD 0/5
Excerpted from ASA's 2022 State of the States Report.
Monthly Donor Button